Press releases | April 7, 2017
Inmedix and Omegawave Announce Unique Strategic Collaboration
SEATTLE – April 7, 2017 – Inmedix, the leader in heart rate variability (HRV) application as an informative diagnostic tool in autoimmune disease, today announced the establishment of a commercial collaboration with Omegawave Ltd. (Espoo, Finland). Omegawave is the industry-leading training and sports performance company used by multiple Olympic Federations, premier soccer teams, franchises from the NFL, MLS, NHL, and MLB as well as by numerous other sports organizations and individual athletes.
Click below to read the full press release.